<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Clonally related composite <z:hpo ids='HP_0002665'>lymphomas</z:hpo> of Hodgkin's <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (<z:e sem="disease" ids="C0019829" disease_type="Neoplastic Process" abbrv="hd">HL</z:e>) and Non-Hodgkin's <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (NHL) represent models to study the multistep transformation process in <z:mp ids='MP_0002006'>tumorigenesis</z:mp> and the development of two distinct <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> from a shared precursor </plain></SENT>
<SENT sid="1" pm="."><plain>We analyzed six such <z:hpo ids='HP_0002665'>lymphomas</z:hpo> for transforming events </plain></SENT>
<SENT sid="2" pm="."><plain>The <z:e sem="disease" ids="C0019829" disease_type="Neoplastic Process" abbrv="hd">HLs</z:e> were combined in two cases with follicular <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (FL), and in one case each with B-cell <z:hpo ids='HP_0005550'>chronic lymphocytic leukemia</z:hpo>, splenic marginal zone <z:hpo ids='HP_0002665'>lymphoma</z:hpo>, mantle cell <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MCL</z:e>) and diffuse large B-cell <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">DLBCL</z:e>) </plain></SENT>
<SENT sid="3" pm="."><plain>In the <z:e sem="disease" ids="C0019829" disease_type="Neoplastic Process" abbrv="hd">HL</z:e>/FL and <z:e sem="disease" ids="C0019829" disease_type="Neoplastic Process" abbrv="hd">HL</z:e>/<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MCL</z:e> combinations, BCL2/IGH and CCND1/IGH translocations, respectively, were detected in both the <z:e sem="disease" ids="C0019829" disease_type="Neoplastic Process" abbrv="hd">HL</z:e> and NHL </plain></SENT>
<SENT sid="4" pm="."><plain>No mutations were found in the <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> suppressor genes FAS, NFKBIA and ATM </plain></SENT>
<SENT sid="5" pm="."><plain>The <z:e sem="disease" ids="C0019829" disease_type="Neoplastic Process" abbrv="hd">HL</z:e>/<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">DLBCL</z:e> case harbored clonal replacement mutations of the TP53 gene on both alleles exclusively in the <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">DLBCL</z:e> </plain></SENT>
<SENT sid="6" pm="."><plain>In conclusion, we present the first examples of molecularly verified IgH-associated translocations in <z:e sem="disease" ids="C0019829" disease_type="Neoplastic Process" abbrv="hd">HL</z:e>, which also show that BCL2/IGH or CCND1/IGH translocations can represent early steps in the pathogenesis of composite <z:e sem="disease" ids="C0019829" disease_type="Neoplastic Process" abbrv="hd">HL</z:e>/FL or <z:e sem="disease" ids="C0019829" disease_type="Neoplastic Process" abbrv="hd">HL</z:e>/<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MCL</z:e> </plain></SENT>
<SENT sid="7" pm="."><plain>The restriction of the TP53 mutations to the <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">DLBCL</z:e> in the <z:e sem="disease" ids="C0019829" disease_type="Neoplastic Process" abbrv="hd">HL</z:e>/<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">DLBCL</z:e> case exemplifies a late transforming event that presumably happened in the germinal center and affected the fate of a common <z:hpo ids='HP_0002665'>lymphoma</z:hpo> precursor cell towards development of a <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">DLBCL</z:e> </plain></SENT>
</text></document>